Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 13,886,539
  • Shares Outstanding, K 136,410
  • Annual Sales, $ 7,515 M
  • Annual Income, $ 645,000 K
  • 36-Month Beta 0.69
  • Price/Sales 1.85
  • Price/Cash Flow 15.17
  • Price/Book 2.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.16 +0.63%
on 09/20/17
108.78 -6.42%
on 09/01/17
-3.07 (-2.93%)
since 08/18/17
3-Month
101.16 +0.63%
on 09/20/17
112.96 -9.88%
on 07/03/17
-6.54 (-6.04%)
since 06/20/17
52-Week
79.12 +28.67%
on 10/28/16
112.96 -9.88%
on 07/03/17
+18.70 (+22.50%)
since 09/20/16

Most Recent Stories

More News
Ziegler Announced as Finalist for Three 16th Annual M&A Advisor Awards

Ziegler, a specialty investment bank, is pleased to announce that it has been nominated for three M&A Advisor awards: Radiology Alliance in its acquisition by MEDNAX, which Ziegler served as the sole...

DGX : 101.80 (-0.06%)
Myriad Genetics Presents Favorable riskScore Test Data

Myriad (MYGN) presenting positive riskScore data at the NSGC conference in Columbus, OH buoys optimism. Notably, with riskScore the company intends to boost its myRisk Hereditary Cancer test suite.

EW : 111.72 (+0.40%)
DGX : 101.80 (-0.06%)
LNTH : 17.45 (+1.16%)
MYGN : 33.51 (+1.82%)
Quest Diagnostics Sustainability Efforts Earn Place on DJSI World Index for Fourteenth Consecutive Year

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index (DJSI)...

DGX : 101.80 (-0.06%)
Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that all of the company's cholesterol test services that involve estimates of low-density...

DGX : 101.80 (-0.06%)
Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in...

DGX : 101.80 (-0.06%)
MS : 47.89 (+0.46%)
Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis

A majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory test...

DGX : 101.80 (-0.06%)
Myriad Genetics Boosts myRisk Hereditary Cancer Test Suite

Myriad Genetics (MYGN) introduces riskScore, a breast cancer prediction tool to broaden its myRisk hereditary cancer test offerings.

EW : 111.72 (+0.40%)
DGX : 101.80 (-0.06%)
LNTH : 17.45 (+1.16%)
MYGN : 33.51 (+1.82%)
Quest Diagnostics (DGX) Banks on Buyouts, Competition Rife

Quest Diagnostics (DGX) witnesses significant growth through infectious disease testing, prescription drug monitoring and wellness business.

EW : 111.72 (+0.40%)
DGX : 101.80 (-0.06%)
LNTH : 17.45 (+1.16%)
IDXX : 158.48 (-1.28%)
Enteric Disease Testing Market Driven by Growing Prevalence of Bacterial & Parasitic Diseases, Says TMR

The key players operating in the enteric disease testing market are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept...

TRIB : 5.40 (+1.12%)
DGX : 101.80 (-0.06%)
BMRA : 2.77 (-0.36%)
CPHD : 52.95 (unch)
ALR : 50.55 (+0.10%)
Medical Research Stocks on Investors' Radar -- China Cord Blood, VWR Corp., Quest Diagnostics, and LabCorp

If you want a Stock Review on CO, VWR, DGX, or LH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, August 28, 2017, US markets saw...

VWR : 33.18 (+0.27%)
DGX : 101.80 (-0.06%)
CO : 11.71 (-2.74%)
LH : 154.15 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Support & Resistance

2nd Resistance Point 103.33
1st Resistance Point 102.57
Last Price 101.80
1st Support Level 101.10
2nd Support Level 100.39

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.